Trial
NCT01329289
SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pittsburgh
Collaborators
Novartis
Condition
Multiple Myeloma in Relapse
Intervention
SOM230
Why stopped
Clinical trial being transferred to Columbia University with the Investigator.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-12